4521 Kaken Pharmaceutical
- 3864.0
- +13.0+0.34%
Kaken Pharmaceutical News
Kaken Pharmaceutical: Conclusion of an agreement for exclusive sales rights for the new wound treatment material “Silk Elastin Wound Sheet”
Kaken Pharmaceutical: Announcement regarding the disposal of treasury stock through third-party allocation due to additional contributions to the performance-based stock compensation system
Kaken Pharmaceutical: Securities registration form (reference method)
Kaken Pharmaceutical: [Summary] Consolidated performance for the first quarter of the fiscal year 2024 (3 months until June 30, 2024) [JGAAP]
Kaken Pharmaceutical: Announcements of individual stocks regarding revisions to financial estimates and dividend forecasts (special dividends).
Kaken Pharmaceutical: 1st quarter financial results SMS for the March 2025 period based on Japanese standards (consolidated).
Kaken Pharmaceutical: Interim report
Kaken Pharmaceutical: Report on Corporate Governance June 27, 2024.
Kaken Pharmaceutical: Confirmatory letter.
Kaken Pharmaceutical: Internal Control Report - 104th Fiscal Year (2023/04/01 - 2024/03/31)
Kaken Pharmaceutical: Securities Report - 104th term (April 1, 2023 - March 31, 2024)
Kaken Pharmaceutical: Change Report
Kaken Pharmaceutical: 2024 Annual General Meeting notice and material for shareholders (revised version).
Kaken Pharmaceutical: Notice of the 2024 Regular Shareholders' Meeting and Partial Revision of Shareholders' Meeting Materials
Kaken Pharmaceutical: Report on the transfer of shares in relation to third-party allotment (treasury stock).
Kaken Pharmaceutical: Notice and conference materials for the annual general meeting in 2024.
Kaken Pharmaceutical: Mass Ownership Report
Kaken Pharmaceutical: 2024 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials
Kaken Pharmaceutical: Independent Officer Notification Form
Kaken Pharmaceutical: Corporate Governance Report 2024/05/30
Analysis
Price Target
No Data
No Data